UBS Group’s AXS Cannabis ETF THCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-408
| Closed | -$6.89K | – | 10366 |
|
|
2023
Q4 | $6.89K | Buy |
408
+289
| +243% | +$4.79K | ﹤0.01% | 7665 |
|
|
2023
Q3 | $2.2K | Buy |
119
+117
| +5,850% | +$2.17K | ﹤0.01% | 7746 |
|
|
2023
Q2 | $39 | Sell |
2
-193
| -99% | -$3.67K | ﹤0.01% | 8629 |
|
|
2023
Q1 | $4.2K | Sell |
195
-159
| -45% | -$3.99K | ﹤0.01% | 8221 |
|
|
2022
Q4 | $9.17K | Buy |
354
+132
| +59% | +$3.93K | ﹤0.01% | 8681 |
|
|
2022
Q3 | $6K | Buy |
222
+159
| +252% | +$5.83K | ﹤0.01% | 9111 |
|
|
2022
Q2 | $2K | Buy |
+63
| New | +$3.31K | ﹤0.01% | 9675 |
|
|
2022
Q1 | – | Sell |
-300
| Closed | -$26K | – | 11167 |
|
|
2021
Q4 | $26K | Buy |
300
+205
| +216% | +$22.5K | ﹤0.01% | 7559 |
|
|
2021
Q3 | $12K | Sell |
95
-297
| -76% | -$43.6K | ﹤0.01% | 7810 |
|
|
2021
Q2 | $67K | Buy |
+392
| New | +$68.6K | ﹤0.01% | 6176 |
|
|
2019
Q4 | – | Sell |
-69
| Closed | -$11K | – | 8498 |
|
|
2019
Q3 | $11K | Buy |
+69
| New | +$14.6K | ﹤0.01% | 7123 |
|
UBS Group's THCX Position: Q1 2024 in Review
UBS Group sold out of AXS Cannabis ETF (THCX) in Q1 2024, closing a stake of 408 shares — an estimated $6.89K sold.
UBS Group first reported a position in THCX in Q3 2019 and held it in 11 quarters. The position peaked at $67K in Q2 2021. 0 funds tracked by Wall St. Rank hold THCX as of Q1 2024.
- UBS Group reported no remaining AXS Cannabis ETF position as of Q1 2024 after selling out during the quarter.
- UBS Group sold 408 AXS Cannabis ETF shares in Q1 2024, an estimated $6.89K.
- UBS Group first reported a position in AXS Cannabis ETF in Q3 2019 and held it in 11 quarters.
- UBS Group's AXS Cannabis ETF position peaked at $67K in Q2 2021.
- 0 funds tracked by Wall St. Rank held AXS Cannabis ETF as of Q1 2024.
Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.